Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristina Panuzzo

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Blood Advances|November 5, 2025
UBE2O AS A KEY REGULATOR OF DRUG-INDUCED ERYTHROPOIESIS IN THE CONTEXT OF MYELODYSPLASTIC SYNDROMESBeatrice Maffeo, Cristina Panuzzo, Arianna Savi, et al.
Oncotarget|August 22, 2015
Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusionSabrina Crivellaro, Cristina Panuzzo, Giovanna Carrà, et al.
Oncotarget|October 22, 2016
Variable but consistent pattern of Meningioma 1 gene (MN1) expression in different genetic subsets of acute myelogenous leukaemia and its potential use as a marker for minimal residual disease detectionSonia Carturan, Jessica Petiti, Valentina Rosso, et al.
Oncotarget|April 19, 2017
Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clonesGiovanna Carrà, Cristina Panuzzo, Davide Torti, et al.
International Journal of Molecular Sciences|March 14, 2026
Clonal Dynamics of FLT3-ITD from Diagnosis to Relapse: Ultra-Sensitive Patient-Specific Monitoring by ddPCRAlessandro Ferrando, Johanna Umurungi, Alice Costanza Danzero, et al.
Cancers|January 20, 2021
Genetic Screening for Potential New Targets in Chronic Myeloid Leukemia Based on Drosophila Transgenic for Human BCR-ABL1Marco Lo Iacono, Elisabetta Signorino, Jessica Petiti, et al.
Oncoscience|December 19, 2015
New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemiaCristina Panuzzo, Gisella Volpe, Elisa Cibrario Rocchietti, et al.
Scientific Reports|July 2, 2024
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemiaPietro Poggio, Stefania Rocca, Federica Fusella, et al.
Cancer Research|June 5, 2007
Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approachesGisella Volpe, Alessandro Cignetti, Cristina Panuzzo, et al.
International Journal of Molecular Sciences|October 21, 2020
Deferasirox-Dependent Iron Chelation Enhances Mitochondrial Dysfunction and Restores p53 Signaling by Stabilization of p53 Family Members in Leukemic CellsChiara Calabrese, Cristina Panuzzo, Serena Stanga, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Blood Advances|November 5, 2025
UBE2O AS A KEY REGULATOR OF DRUG-INDUCED ERYTHROPOIESIS IN THE CONTEXT OF MYELODYSPLASTIC SYNDROMESBeatrice Maffeo, Cristina Panuzzo, Arianna Savi, et al.
Oncotarget|August 22, 2015
Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusionSabrina Crivellaro, Cristina Panuzzo, Giovanna Carrà, et al.
Oncotarget|October 22, 2016
Variable but consistent pattern of Meningioma 1 gene (MN1) expression in different genetic subsets of acute myelogenous leukaemia and its potential use as a marker for minimal residual disease detectionSonia Carturan, Jessica Petiti, Valentina Rosso, et al.
Oncotarget|April 19, 2017
Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clonesGiovanna Carrà, Cristina Panuzzo, Davide Torti, et al.
International Journal of Molecular Sciences|March 14, 2026
Clonal Dynamics of FLT3-ITD from Diagnosis to Relapse: Ultra-Sensitive Patient-Specific Monitoring by ddPCRAlessandro Ferrando, Johanna Umurungi, Alice Costanza Danzero, et al.
Cancers|January 20, 2021
Genetic Screening for Potential New Targets in Chronic Myeloid Leukemia Based on Drosophila Transgenic for Human BCR-ABL1Marco Lo Iacono, Elisabetta Signorino, Jessica Petiti, et al.
Oncoscience|December 19, 2015
New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemiaCristina Panuzzo, Gisella Volpe, Elisa Cibrario Rocchietti, et al.
Scientific Reports|July 2, 2024
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemiaPietro Poggio, Stefania Rocca, Federica Fusella, et al.
Cancer Research|June 5, 2007
Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approachesGisella Volpe, Alessandro Cignetti, Cristina Panuzzo, et al.
International Journal of Molecular Sciences|October 21, 2020
Deferasirox-Dependent Iron Chelation Enhances Mitochondrial Dysfunction and Restores p53 Signaling by Stabilization of p53 Family Members in Leukemic CellsChiara Calabrese, Cristina Panuzzo, Serena Stanga, et al.
Pageof 5